Beddow Capital Management Lowered Its Chevron (CVX) Holding by $2.21 Million; Stock Declined; Raab & Moskowitz Asset Management Cut Cvs Health Com (CVS) Holding by $515,736 as Market Value Declined

April 22, 2018 - By Clifton Ray

CVS Health Corporation (NYSE:CVS) Logo

Raab & Moskowitz Asset Management Llc decreased its stake in Cvs Health Corp Com (CVS) by 23.89% based on its latest 2017Q4 regulatory filing with the SEC. Raab & Moskowitz Asset Management Llc sold 7,163 shares as the company’s stock declined 17.45% with the market. The institutional investor held 22,821 shares of the medical and nursing services company at the end of 2017Q4, valued at $1.65M, down from 29,984 at the end of the previous reported quarter. Raab & Moskowitz Asset Management Llc who had been investing in Cvs Health Corp Com for a number of months, seems to be less bullish one the $66.20 billion market cap company. The stock decreased 0.37% or $0.24 during the last trading session, reaching $65.12. About 6.17 million shares traded. CVS Health Corporation (NYSE:CVS) has declined 22.81% since April 22, 2017 and is downtrending. It has underperformed by 34.36% the S&P500.

Ed Beddow decreased its stake in Chevron Corp (CVX) by 57.33% based on its latest 2017Q4 regulatory filing with the SEC. Beddow Capital Management Inc sold 17,702 shares as the company’s stock declined 8.26% with the market. The hedge fund run by Ed Beddow held 13,173 shares of the integrated oil company at the end of 2017Q4, valued at $1.65M, down from 30,875 at the end of the previous reported quarter. Beddow Capital Management Inc who had been investing in Chevron Corp for a number of months, seems to be less bullish one the $233.64 billion market cap company. The stock decreased 1.13% or $1.4 during the last trading session, reaching $122.31. About 7.56 million shares traded or 1.79% up from the average. Chevron Corporation (NYSE:CVX) has risen 7.88% since April 22, 2017 and is uptrending. It has underperformed by 3.67% the S&P500.

Raab & Moskowitz Asset Management Llc, which manages about $207.27M US Long portfolio, upped its stake in Cisco Sys Inc Com (NASDAQ:CSCO) by 9,028 shares to 15,435 shares, valued at $591,000 in 2017Q4, according to the filing.

Among 26 analysts covering CVS Health (NYSE:CVS), 19 have Buy rating, 0 Sell and 7 Hold. Therefore 73% are positive. CVS Health had 76 analyst reports since July 22, 2015 according to SRatingsIntel. The rating was initiated by Barclays Capital on Friday, December 18 with “Overweight”. Needham upgraded the shares of CVS in report on Tuesday, January 30 to “Buy” rating. The stock of CVS Health Corporation (NYSE:CVS) has “Hold” rating given on Thursday, August 20 by Deutsche Bank. Robert W. Baird maintained the shares of CVS in report on Thursday, January 4 with “Hold” rating. Citigroup maintained the stock with “Neutral” rating in Thursday, August 17 report. The company was downgraded on Monday, December 12 by Jefferies. Barclays Capital reinitiated CVS Health Corporation (NYSE:CVS) rating on Thursday, March 10. Barclays Capital has “Overweight” rating and $115 target. Mizuho maintained the stock with “Buy” rating in Wednesday, November 9 report. The firm has “Overweight” rating by JP Morgan given on Monday, November 2. The rating was maintained by RBC Capital Markets with “Outperform” on Wednesday, August 5.

Analysts await CVS Health Corporation (NYSE:CVS) to report earnings on May, 2 before the open. They expect $1.40 earnings per share, up 19.66% or $0.23 from last year’s $1.17 per share. CVS’s profit will be $1.42 billion for 11.63 P/E if the $1.40 EPS becomes a reality. After $1.92 actual earnings per share reported by CVS Health Corporation for the previous quarter, Wall Street now forecasts -27.08% negative EPS growth.

Investors sentiment decreased to 0.72 in Q4 2017. Its down 0.16, from 0.88 in 2017Q3. It is negative, as 115 investors sold CVS shares while 600 reduced holdings. 134 funds opened positions while 380 raised stakes. 815.59 million shares or 1.76% more from 801.45 million shares in 2017Q3 were reported. Sit Inv Assoc Incorporated holds 0.02% or 14,030 shares in its portfolio. Gofen And Glossberg Limited Com Il accumulated 36,288 shares. Rampart Investment Co Ltd holds 0.35% or 12,464 shares in its portfolio. Peak6 LP accumulated 113,404 shares. Glenview Cap Management Limited Liability reported 6.82M shares. Dumont And Blake Invest Advsr Ltd stated it has 0.45% of its portfolio in CVS Health Corporation (NYSE:CVS). Glg Ptnrs Limited Partnership has invested 0.01% in CVS Health Corporation (NYSE:CVS). Kidder Stephen W invested 2.48% of its portfolio in CVS Health Corporation (NYSE:CVS). Adell Harriman & Carpenter invested 0.05% in CVS Health Corporation (NYSE:CVS). Birch Hill Invest Advisors Ltd Liability Corp accumulated 46,821 shares or 0.28% of the stock. Virtu Financial Ltd Co, New York-based fund reported 5,556 shares. Banced Corporation reported 0.7% of its portfolio in CVS Health Corporation (NYSE:CVS). Moreno Evelyn V, a Massachusetts-based fund reported 91,681 shares. 1.19 million were reported by Westwood Hldg Grp Inc. 108,184 were reported by Culbertson A N And Communications Incorporated.

Since February 16, 2018, it had 0 buys, and 1 sale for $1.42 million activity.

Beddow Capital Management Inc, which manages about $385.61M and $246.75 million US Long portfolio, upped its stake in Helmerich & Payne Inc. (NYSE:HP) by 39,481 shares to 152,046 shares, valued at $9.83M in 2017Q4, according to the filing. It also increased its holding in Pfizer Inc (NYSE:PFE) by 59,300 shares in the quarter, for a total of 275,965 shares, and has risen its stake in Natus Medical Inc (NASDAQ:BABY).

Investors sentiment increased to 0.99 in 2017 Q4. Its up 0.04, from 0.95 in 2017Q3. It is positive, as 51 investors sold CVX shares while 686 reduced holdings. 122 funds opened positions while 608 raised stakes. 1.19 billion shares or 0.58% more from 1.18 billion shares in 2017Q3 were reported. Argent Co invested in 2.53% or 75,400 shares. Alexandria Ltd holds 0.07% or 3,880 shares. Hudock Capital Ltd Liability reported 19,062 shares or 1.04% of all its holdings. 18,974 were accumulated by Peoples Fincl Svcs Corp. Destination Wealth Management has 228,147 shares for 1.73% of their portfolio. Sun Life Fin Inc has 18,424 shares for 0.24% of their portfolio. Renaissance Invest Grp Inc Lc owns 4,547 shares for 0.23% of their portfolio. Parsec Financial Mgmt reported 1.26% of its portfolio in Chevron Corporation (NYSE:CVX). Pillar Pacific Capital Ltd Liability Com reported 59,505 shares stake. Coho Partners Limited invested in 962,143 shares. Fort Washington Inv Advisors Inc Oh has invested 0.39% in Chevron Corporation (NYSE:CVX). Tru Com Of Virginia Va owns 73,345 shares. Cap Research Global Investors accumulated 10.37M shares. Eagle Asset Mngmt holds 0.48% or 732,715 shares in its portfolio. Ny State Teachers Retirement Systems invested in 0.96% or 3.23 million shares.

Among 35 analysts covering Chevron Corporation (NYSE:CVX), 26 have Buy rating, 0 Sell and 9 Hold. Therefore 74% are positive. Chevron Corporation had 119 analyst reports since August 4, 2015 according to SRatingsIntel. The company was upgraded on Wednesday, March 9 by Wolfe Research. The stock of Chevron Corporation (NYSE:CVX) earned “Overweight” rating by JP Morgan on Friday, September 11. The stock of Chevron Corporation (NYSE:CVX) earned “Market Perform” rating by Raymond James on Tuesday, March 22. The firm earned “Buy” rating on Tuesday, February 6 by Wells Fargo. On Tuesday, December 15 the stock rating was maintained by JP Morgan with “Overweight”. The rating was upgraded by Macquarie Research on Tuesday, October 17 to “Buy”. As per Wednesday, January 24, the company rating was maintained by Morgan Stanley. Credit Suisse maintained Chevron Corporation (NYSE:CVX) rating on Tuesday, January 23. Credit Suisse has “Hold” rating and $130.0 target. The stock of Chevron Corporation (NYSE:CVX) earned “Buy” rating by Bank of America on Tuesday, October 3. The stock of Chevron Corporation (NYSE:CVX) earned “Buy” rating by Jefferies on Wednesday, April 12.

Analysts await Chevron Corporation (NYSE:CVX) to report earnings on April, 27 before the open. They expect $1.48 EPS, up 4.96% or $0.07 from last year’s $1.41 per share. CVX’s profit will be $2.83 billion for 20.66 P/E if the $1.48 EPS becomes a reality. After $0.73 actual EPS reported by Chevron Corporation for the previous quarter, Wall Street now forecasts 102.74% EPS growth.

Chevron Corporation (NYSE:CVX) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.





Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter:


Recent Posts